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Abstract		
	
Objectives:	To	identify	any	seasonal	variation	in	the	occurrence	of,	and	outcome	
following	Acute	Kidney	Injury.	
	
Methods:	The study utilised the biochemistry based AKI electronic (e)-alert system 
established across the Welsh National Health Service to collect data on all AKI 
episodes to	identify	changes	in	incidence	and	outcome	over	one	calendar	year	(1st	
October	2015	and	the	30th	September	2016).	
	
Results:	 There	 were	 are	 total	 of	 48,457	 incident	 AKI	 alerts.	 	 The	 highest	
proportion	 of	 AKI	 episodes	was	 seen	 in	 the	 quarter	 of	 January	 to	March	
(26.2%),	 and	 the	 lowest	 in	 the	 quarter	 of	 October	 to	 December	 (23.3%,	
p<0.001).		The	same	trend	was	seen	for	both	community-acquired	and	hospital-
acquired	 AKI	 sub-sets.	 	 Overall	 90-day	 mortality	 for	 all	 AKI	 was	 27.3%.	 In	
contrast	 to	 the	 seasonal	 trend	 in	 AKI	 occurrence,	 90-day	 mortality	 after	 the	
incident	AKI	alert	was	significantly	higher	in	the	quarters	of	January	to	March	
and	October	to	December	compared	to	the	quarters	of	April	to	June	and	July	
to	 September	 (p<0.001)	 consistent	with	excess	winter	mortality	 reported	 for	
likely	underlying	diseases	which	precipitate	AKI.		
	
Conclusion:	In	summary	we	report	for	the	first	time	in	a	large	national	cohort,	a	
seasonal	 variation	 in	 the	 incidence	 and	 outcomes	 of	 AKI.	 	 The	 results	
demonstrate	distinct	trends	in	the	incidence	and	outcome	of	AKI.			
	
	
What	is	known.	
Seasonal	variation	in	diseases	associated	with	the	development	of	AKI	has	been	
previously	reported.	
What	this	study	adds.	
This	is	the	first	study	to	describe	seasonal	variation	in	the	number	of	AKI	cases	
and	associated	mortality.		 	
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Introduction	
AKI	is	a	clinical	syndrome	characterized	by	rapid	loss	of	kidney	function,	and	is	
associated	with	adverse	patient	outcomes	[1-5].		It	is	estimated	to	occur	in	up	to	
15%	of	hospitalized	patients	and	up	to	60%	of	critically	ill	patients	[2,	3,	6]	.		The	
estimated	 cost	 of	 AKI	 to	NHS	 England	 is	 £1	 billion/year	 or	 roughly	 1%	 of	 the	
total	NHS	budget	[7].				
	
Significant	weaknesses	in	patient	management	have	been	widely	reported	[8,	9].			
In	the	U.K.	the	National	Confidential	Enquiry	report	highlighted	sub-optimal	care	
of	AKI	patients	which	may	subsequently	 translate	 into	episodes	of	preventable	
harm	 [10].	 	 This	 has	 driven	 initiatives	 to	 facilitate	 early	 detection	 and	
intervention	 in	 order	 to	 improve	 patient	 outcomes.	 	 In	 response	 the	 Royal	
College	 of	 Physicians,	 at	 a	 consensus	 conference	 in	 the	 UK,	 recommended	 the	
adoption	of	an	e-alert	system	to	aid	 in	the	early	 identification	of	AKI	[11].	 	The	
presumed	 benefits	 of	 early	 detection	 of	 AKI	 has	 led	 to	 the	 development	 of	 an	
automated	an	AKI	electronic	alert	system	in	in Wales, and the other home countries 
of the United Kingdom [12].  Electronic	alerts	are	generated	by	comparing	a	single	
serum	 creatinine	 measurement	 with	 previous	 measurements	 for	 the	 same	
patient,	 and	 flagging	 any	 results	which	 represent	 a	 rise	 in	 creatinine	 equating	
AKI	[13].	 	In	addition	to	prompting	clinicians	to	intervene	at	an	early	stage,	this	
also	provides	a	valuable	source	of	data	regarding	 the	epidemiology	of	AKI.	 	We	
have	previously	used	this	data	set	to	report	the	incidence	and	outcome	of	AKI	in	
adult	[14]	and	paediatric	patients	[15]	 in	Wales	(U.K.).	 	 	More	recently	we	have	
demonstrated	the	significance	of	the	electronic	AKI	alert	in	primary	care	[16].			
	
Despite	advances	in	health	care,	the	incidence	of	AKI	is	increasing	both	in	the	UK	
[17,	18]	and	USA	[19,	20].		Potential	explanations	for	this	increase	may	be	related	
to	 increasingly	 aggressive	 medical	 and	 surgical	 therapies	 in	 a	 largely	 aging	
population	with	multiple	comorbid	conditions	[21].		In	the	majority	of	cases	AKI	
is	a	secondary	to	other	disease	states	and	critical	illness	rather	than	a	reflection	
of	primary	intrinsic	renal	disease.		Alterations	in	the	patterns	of	these	underlying	
diseases	 may	 therefore	 also	 contribute	 to	 the	 increased	 incidence	 of	 AKI.		
Seasonal	variations	have	been	described	in	many	diseases	which	may	precipitate	
AKI.		In	contrast	to	date	there	are	no	studies	which	address	seasonal	variations	in	
the	incidence	and	outcome	of	AKI.		Using	our	data	set	generated	from	electronic	
AKI	alerts	in	this	manuscript	we	describe	the	seasonal	trends	for	AKI	over	a	one-
year	period.		The	data	captures	all	cases	of	AKI	in	both	community	and	hospital	
settings	with	AKI	being	defined	by	change	in	creatinine	criteria.			
	
Methods	
Electronic	 Reporting	 of	 AKI:	 The	 previously	 described	 (and	 validated)	Welsh	
electronic	AKI	reporting	system	[22],	utlitises	the	Welsh	Laboratory	Information	
Management	 System	 (LIMS),	 (InterSystems	 TrakCare	 Lab)	 to	 automatically	
compare	in	real	time	measured	creatinine	values	on	an	individual	patient	against	
previous	results.		This	generates	electronic	AKI	alerts,	derived	from	a	nationally	
agreed	algorithm	based	on	KDIGO	AKI	criteria	[12].	
	
The	study	was	approved	under	Service	Evaluation	Project	Registration.			
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Data	Collection:	Data	was	collected	for	all	cases	of	adult	(≥18yrs	of	age)	AKI	in	
Wales	 between	1st	October	 2015	 and	 the	 30th	 September	 2016,	 and	 organised	
into	quarters.		The	“calendar”	year	was	divided	into	four	quarters:	 January	
to	March	(Jan-Mar),	April	to	June	(Apr-Jun),	July	to	September	(Jul-Sep)	and	
October	 to	December	 (Oct-Dec).	 	Clinical	 location,	patient	age,	AKI	stage	and	
the	rule	under	which	the	AKI	alert	was	generated	was	collected	together	with	all	
measurements	 of	 renal	 function	 for	 up	 to	 30	 days	 following	 the	 AKI	 alert.	 To	
prevent	inclusion	of	known	patients	receiving	renal	replacement	therapy,	alerts	
transmitted	by	patients	from	a	renal,	renal	transplant,	or	dialysis	setting,	and	by	
patients	who	had	a	previous	blood	test	in	a	dialysis	unit	were	excluded.		
	
Mortality	 data	 were	 collected	 from	 the	 Welsh	 Demographic	 Service	 (WDS).	
Patients	were	censored	at	1	year	for	survival	analysis.		
	
Data	analysis:	All	patients	for	which	the	first	alert	was	issued	during	a	hospital	
admission	who	also	had	a	normal	SCr	value	generated	in	a	hospital	setting	within	
the	preceding	seven	days	were	defined	as	Hospital	acquired	(HA)-AKI.	Patients	
alerting	 in	 a	 non-inpatient	 setting	 (including	 Accident	 and	 Emergency/Acute	
assessment	 units)	 and	 not	 alerting	 in	 primary	 care	 were	 classified	 as	 non-
primary	care	community	acquired	(CA)-AKI.		Primary	care	and	non-primary	care	
CA-AKI	 therefore	collectively	represent	CA-AKI.	 	Hospitalisation of CA-AKI, was 
defined as a measurement of renal function in a hospital setting within 7 days 
following the AKI e-alert.  4399	 (9.1%)	patients	whilst	 alerting	 in	an	 in-patient	
setting	 had	 no	 results	 for	 the	 previous	 7	 days.	 	 As	 these	 patients	 did	 not	
therefore	 fall	 into	 either	 CA-	 or	 HA-	 definitions,	 they	 were	 excluded	 from	 the	
subgroup	analysis.		 
	
An	incident	AKI	episode	was	defined	as	30	days	i.e.	any	AKI	e-alert	for	the	same	
patient	 within	 30	 days	 the	 incident	 alert	 was	 not	 considered	 a	 new	 episode.		
Progression of AKI was defined as a peak AKI stage higher than that associated with 
incident e-alert or for stage 3 alerts an increase ≥50% from the SCr generating the 
alert. Pre-existing	 chronic	 kidney	 disease	 (PeCKD)	 was	 defined	 as	 an	 eGFR	
(calculated	by	CKDEpi	eGFR	formula	[23])	<60ml/min/1.73m2	derived	from	the	
baseline	SCr.			
	
Statistical	 significance	was	 determined	 by	 one	way	 ANOVA,	 student	 t	 test	 and	
Chi2	 test	as	appropriate.	The	 influence	of	age,	 sex	and	pre-existing	CKD	on	AKI	
incidence	 was	 assessed	 by	 logistic	 regression.	 	 P	 values	 less	 than	 0.05	 were	
considered	statistically	significant.		
	
Results	
Seasonal	trends	in	AKI	episodes:	
Over	 the	 study	 period	 there	 were	 a	 total	 of	 48,457	 incident	 AKI	 alerts,	 and	 a	
progressive	 fall	 in	 the	number	of	AKI	episodes	 in	each	quarter	of	 the	calendar	
year	(Table	1	and	Figure	1A),	with	the	proportion	of	AKI	 falling	 from	26.2%	in	
the	quarter	 of	 Jan-Mar	 to	 23.3%	 in	 the	quarter	 of	 Oct-Dec	 (p<0.001).	 	 The	
seasonal	 trend	 in	 AKI	 occurrence	was	 not	 associated	with	 differences	 in	 basic	
patient	demographic	as	assessed	by	sex,	age	or	pre-existing	CKD	(Table	1).			In a 
logistic regression model age, gender and pre-existing CKD had no influence on the 
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primary outcome i.e. seasonal variation in AKI.	 	As	a	results	age adjusted incidence 
of AKI in each season also demonstrated a fall from 25.9% in Jan-Mar to 23.8% in 
Oct-Dec (p<0.001). 	
	
Incidence	of	CA-AKI:	 	Of	all	AKI	which	occurred	during	 the	 study	period	49.9%	
were	 CA-AKI	 alerts	 (Table	 2).	 	 This	 represents	 a	 total	 of	 24,178	 alerts.	 The	
number	 of	 CA-AKI	 episodes	 varied	 across	 the	 year	 (Figure	 1B).	 	 The	 highest	
number	 (6265)	 was	 seen	 in	 Jan-Mar,	 and	 there	 were	 significantly	 fewer	
episodes	(5632)	during	the	Oct-Dec	compared	to	each	of	the	preceding	quarters	
(p<0.001	for	comparison	of	Oct-Dec	vs.	each	of	the	other	quarters).		
	
31.5%	 of	 CA-AKI	 represented	 alerts	 generated	 in	 Primary	 care	 (GP-AKI),	 and	
48.4%	represented	patients	alerting	at	the	hospital	front	door	(A&E	AKI).	 	Both	
cohorts	 demonstrated	 the	 same	 seasonal	 trends	 with	 a	 significantly	 lower	
number	 of	 AKI	 alerts	 in	Oct-Dec	 (Table	 2).	 	 	 Only	 42.9%	 of	 all	 CA-AKI	 were	
admitted	 to	 hospital	 following	 the	 alert.	 The	 same	 seasonal	 trends	 seen	 in	 the	
whole	cohort	 (with	 the	 lowest	number	seen	 in	Oct-Dec)	was	also	seen	 in	both	
the	admitted	and	non-admitted	groups	(Table	2).		
	
Incidence	of	HA-AKI:	Of	all	AKI	that	occurred	during	the	study	period	41.0%	were	
HA-AKI	alerts	(Table	3).		This	represents	a	total	of	19,880	alerts.	The	number	of	
hospital	acquired	AKI	episodes	varied	across	the	year	(Figure	2C).	 	The	number	
of	 HA-AKI	 episodes	 in	 Jan-March	 (5334),	 was	 statistically	 greater	 than	 the	
number	of	 episodes	 in	 all	other	quarters.	The	 comparative	 fall	 in	 each	quarter	
was	 statistically	 significant,	with	 the	 lowest	number	of	 cases	being	 seen	 in	 the	
quarter	 of	 Oct-Dec	 (4569).	 	 The	 seasonal	 trend	 in	 AKI	 occurrence	was	 not	
associated	with	differences	in	basic	patient	demographic	as	assessed	by	sex,	age	
or	pre-existing	CKD.		
	
In	 the	absence	of	 clinical	data,	 to	provide	 insight	 into	 the	nature	of	HA-AKI	we	
analysed	 the	 seasonal	 incidence	 of	 AKI	 in	 relation	 to	 the	 clinical	 speciality	 in	
which	 the	 alert	was	 generated	 (Table	4).	 	 	Only	 specialities	 in	which	≥200	AKI	
episodes	were	documented	during	the	year	were	included	in	this	analysis.	 	The	
decreasing	 trend	of	AKI	 incidence	throughout	 the	calendar	year	was	significant	
in	 the	 majority	 of	 the	 medical	 specialties,	 the	 exceptions	 being	
hematology/oncology	and	endocrinology.		It	should	however	be	noted	that	these	
two	 specialties	 also	 had	 the	 fewest	 number	 of	 episodes.	 Within	 the	 surgical	
specialties	 the	 pattern	 of	 falling	 numbers	 was	 seen	 in	 General	 surgical	 and	
urology	 locations	 only,	 and	 no	 seasonal	 changes	 in	 AKI	 occurrence	 was	 seen	
related	to	Trauma,	Obstetrics	and	Gynecology	nor	Cardiothoracic	location	codes.			
	
	
Seasonal	trends	in	AKI	outcomes		
Overall	90-day	mortality	for	all	AKI	was	27.3%	(Table	1).	90-day	mortality	after	
the	incident	AKI	alert	was	significantly	higher	in	the	quarters	of	Jan-March	
and	Oct-Dec	compared	to	the	Apr-Jun	and	Jul-Sep	quarters	(p<0.001).		
	
CA-AKI:	90-day	mortality	was	also	significantly	higher	following	an	incident	CA-
AKI	alert,	in	the	Jan-Mar	and	Oct-Dec	quarters	(Table	2).	CA-AKI	severity	was	
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also	highest	in	these	quarters	with	a	higher	proportion	of	AKI	stage	2/3.	ICU	
admission	was	also	used	as	a	surrogate	marker	of	disease	severity.		In	the	same	
two	quarters	a	higher	proportion	of	AKI	episodes	required	support	in	an	
Intensive	Care	Unit	(ICU)	setting.		
	
HA-AKI:	As	with	CA-AKI,	90-day	mortality	was	 significantly	higher	 following	 an	
alert	 in	 the	 Jan-Mar	 and	 Oct-Dec	 quarters	 (Table	 3).	 	 For	 this	 subgroup	
however,	there	was	no	significant	difference	in	AKI	severity	throughout	the	year,	
as	 assessed	 by	 AKI	 stage	 at	 presentation,	 and	 the	 proportion	 of	 patients	
requiring	support	in	the	ICU.	 
	
Discussion		
The	majority	 of	 publications	 of	 large	 series	 characterising	 AKI	 rely	 on	making	
and	 recording	 an	 accurate	 diagnosis	 of	 AKI	 through	 hospital	 coding	 or	
retrospective	review	of	hospital	records	[24-27].		As	a	result	most	studies	of	AKI	
focus	 on	hospitalised patients [4, 8, 24, 26-29], and do not include all  community 
acquired AKI, as a significant proportion of AKI in these settings do not result in 
hospitalisation [30-34].  We have previously demonstrated that using the electronic 
AKI data set provides a comprehensive characterisation of AKI across both 
community and hospital settings [14]. Our data therefore provides a comprehensive 
overview of trends of all cases of AKI defined by changes in serum creatinine.  It 
should be noted however that any patients for which there are no results on the system 
existing from the previous 365 days will not be identified, although these cases may 
represent AKI. Currently any abnormal serum creatinine result with no baseline 
creatinine comparator is highlighted as an abnormal result requiring clinician scrutiny, 
but is not included in our data.  
 
The	data	presented	represent	the	first	study	to	describe	the	seasonal	variation	in	
the	 number	 of	 episodes	 of	 AKI	 in	 a	 large	 national	 cohort.	 	 Whilst	 seasonal	
changes	in	disease	patterns	have	been	described	for	a	number	of	illnesses,	there	
is	no	published	data	regarding	whether	this	affects	the	seasonal	incidence	of	AKI.		
Our	 data	 demonstrates	 that	 there	 is	 a	 significant	 seasonal	 variation	 in	 the	
incidence	 of	 all	 AKI	 with	 a	 significant	 decreasing	 trend	 in	 the	 incidence	
throughout	the	calendar	year.			
 
In	this	manuscript	it	is	evident	that	the	seasonal	patterns	for	AKI	are	similar	for	
both	CA-AKI	and	HA-AKI.	 	For	CA-AKI	the	trend	is	consistent	for	both	the	cases	
admitted	 and	 managed	 in	 the	 community,	 as	 well	 as	 those	 cases	 detected	 in	
primary	 care	 and	 at	 the	 hospital	 front	 door.	 	 This	 pattern	 therefore	 does	 not	
reflect	 the	widely	reported	winter	rise	 in	emergency	medical	pressures	 in	NHS	
hospitals	 across	 the	 United	 Kingdom	 which	 is	 accepted	 to	 reflect	 admissions	
related	 to	 respiratory	 and	 cardiovascular	 illness	 [35].	 	Within	 the	HA-AKI	 AKI	
cohort,	and	in	the	absence	of	clinical	data,	we	used	the	location	of	the	AKI	alerts	
to	provide	some	insight	into	the	potential	causes	of	AKI.	The	seasonal	trend	for	a	
fall	in	incidence	was	consistent	across	the	majority	of	medical	specialties.		Within	
surgical	 specialties	however	 the	 fall	 in	 the	number	of	 episodes	 throughout	 the	
year	was	seen	for	alerts	generated	in	general	surgical	and	urology	location	codes	
only	 and	 not	 in	 in	 trauma	 nor	 cardiothoracic	 locations.	 	 	 It	 is	 interesting	 to	
speculate	 that	 in	 the	 latter	 two	specialties	clinical	activity	 in	not	a	reflection	of	
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“illness”.		Trauma	cases	relate	to	“human	behavior	patterns”	rather	than	disease	
and	 tend	 to	 reflect	 patterns	 of	weather	 and	 temperature	whilst	 cardiothoracic	
surgery	 activity	 generally	 reflects	 elective	 planned	 surgery	 which	 leads	 to	 a	
consistent	 number	 of	 procedures	 throughout	 the	 year.	 In	 contrast,	 for	medical	
specialties	 and	 general	 surgery,	 clinical	 activity	 is	 more	 closely	 associated	 to	
“illness”	 rather	 than	 elective	 activity,	 although	 we	 are	 unable	 to	 distinguish	
between	elective	and	emergency	cases	and	this	therefore	remains	speculative.			
 
Whilst	 demonstrating	 a	 significant	 trend	our	data	does	not	however	provide	 a	
clear	explanation	 for	 this	 trend	as	 the	e-alert	system	is	 IT	driven	and	based	on	
creatinine	 values	 only.	 	 There	 is	 therefore	 no	 clinical	 context	which	 precludes	
inclusion	 of	 clinical	 information,	 such	 as	 patient	 co-morbidity	 and	 linkage	 to	
primary	care	data	sets.		It	also	lacks	the	detail	of	the	cause	of	AKI.		In	the	majority	
of	cases	AKI	does	not	represent	intrinsic	kidney	disease	but	rather	a	response	to	
other	 primary	 illness	 which	 leads	 to	 reduced	 renal	 perfusion.	 	 The	 seasonal	
variation	 in	 AKI	 incidence	 is	 therefore	 likely	 to	 reflect	 that	 common	
causes/precipitants	of	AKI	demonstrate	seasonal	variation.		Seasonal	variation	in	
disease	 presentations	 and	 hospital	 admissions	 is	 a	 well-described	
phenomenon.		For	example,	acute	myocardial	infarction	is	more	common	during	
winter	and	spring	[36,	37].		Whilst	the	explanation	for	this	remains	unclear	it	is	
postulated	 that	 the	 likely	 link	 is	 the	 association	 between	 variation	 in	
temperature	 and	 biological	 factors	 which	 contribute	 to	 disease	 pathogenesis	
such	 as	 blood	 pressure	 [38]	 and	 other	 metabolic	 factors	 [39,	 40].		
Epidemiological	 studies	 in	 diabetes	 have	 demonstrated	 that	 hypoglycaemic	
episodes	 are	 more	 common	 during	 summer	 months,	 whilst	 hyperglycaemic	
complications	 are	 more	 common	 in	 the	 first	 months	 of	 the	 year,	 with	 said	
patterns	 ascribed	 to	 changes	 in	 calorie	 consumption	 and	physical	 activity	 [41-
43].	 	 Increased	 incidence	 of	 Gram-negative	 bacteraemia	 has	 been	 reported	 in	
summer	 months	 and	 associated	 with	 elevated	 monthly	 outdoor	 temperatures	
[44-46].	 	 Community	 acquired	 pneumonia	 in	 contrast	 is	more	 common	 in	 the	
spring	 and	 winter,	 as	 a	 result	 of	 	 the	 combination	 of	 circulating	 respiratory	
bacteria	being	more	prevalent	during	colder	seasons,	and	people	spending	more	
time	 indoors	 during	 colder	 months	 [47,	 48].	 	Trauma	 is	 another	 potential	
predisposing	 factor	 for	 the	 development	 of	 AKI.	 	Studies	 have	 shown	 that	 in	
paediatric	 cohorts,	 admissions	 relating	 to	 trauma	 are	 highest	 during	 summer	
months,	presumably	as	children	spend	more	time	playing	outdoors	during	these	
warmer	 months.	 	In	 contrast,	 adults	 are	 more	 likely	 to	 be	 admitted	 with	
significant	 trauma	 during	 winter	 months,	 due	 to	 an	 increase	 in	 falls	 and	
accidents	 relating	 to	 ice/snow	 [49].	 	 	 It	 is	 likely	 that	 each	 of	 these	
aforementioned	 diseases	 influence	 the	 seasonal	 variation	 of	 AKI	 and	 further	
studies	 are	 required	 focusing	on	 the	precipitating	 factors	which	 lead	 to	AKI	 to	
provide	a	robust	link	between	disease	aetiology	and	the	seasonal	variation	that	
we	have	described.	 	A striking and somewhat unexpected observation in this study 
however is the consistency of the seasonal trend across all of the sub-groups of AKI 
that we have examined. 
	
	
In	 addition	 to	 the	 seasonal	 effect	 of	 disease	 incidence	we	have	 also	 found	 and	
temporal	 association	 with	 outcome	 following	 AKI.	 	 There	 was	 however	 a	
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disconnect	between	seasonal	trends	in	incidence	and	outcome	as	mortality	was	
highest	 in	 the	 first	and	 fourth	quarters	of	 the	calendar	year,	 that	 is	during	the	
winter	 months.	 	 This	 is	 again	 consistent	 across	 CA-	 and	 HA-AKI.	 	 For	 CA-AKI	
mortality	was	associated	with	disease	severity	at	presentation	as	the	AKI	stage	at	
presentation	 was	 also	 higher	 in	 these	 two	 quarters,	 as	 was	 the	 need	 for	 ICU	
support.	 	 This	 association	 with	 AKI	 severity	 as	 assessed	 by	 these	 simple	
parameters	 were	 not	 however	 apparent	 for	 HA-AKI	 patients.	 This	 pattern	 of	
mortality	 is	 reflective	 of	 the	 accepted	 patterns	 of	 mortality	 associated	 with	
“winter	pressures”.		Excess	winter	mortality	has	been	described	in	studies	dating	
back	 over	 a	 century	 [50],	 with	 an	 increase	 in	 all	 cause	 mortality,	 	 mortality	
related	to	cardiovascular	disease,	stroke,	respiratory	disease	and	gram	negative	
bacteraemia	 all	 being	 reported	 [51-53]	 .	 In	 the	majority	 of	 cases	AKI	 does	 not	
represent	 intrinsic	 renal	 disease	but	 occurs	 as	 a	 result	 of	 dysfunction	 of	 other	
organs	 leading	 to	 septic,	 ischemic	 or	 toxic	 insults	 to	 the	 kidneys.	 	 Although	
without	 additional	 clinical	 information	 our	 data	 set	 does	 not	 shed	 light	 on	 the	
cause	of	death,	 it	 is	 likely	 that	 the	seasonal	 trends	 in	mortality	reflect	different	
patterns	 of	 mortality	 associated	 with	 the	 primary	 underlying	 diseases	 which	
precipitate	AKI.		
	
In	 summary	we	 report	 for	 the	 first	 time	 in	 a	 large	 national	 cohort,	 a	 seasonal	
variation	in	the	incidence	and	outcomes	of	AKI.		The	results	demonstrate	distinct	
trends	in	the	incidence	and	outcome	of	AKI.		Incidence	of	AKI	fell	throughout	the	
four	quarters	of	the	calendar	year	whilst	mortality	was	higher	in	the	quarters	of	
January	 to	March	and	October	 to	December	reflecting	well	described	excess	
winter	 mortality	 association	 with	 numerous	 primary	 illnesses	 which	 may	
precipitate	 AKI.	 	This	 study	was	 derived	 from	 a	 biochemical	 data	 set.	 	 Further	
studies	 are	 therefore	 needed,	 in	which	 data	 on	 clinical	 diagnosis	 and	 cause	 of	
death	are	captured	to	provide	a	detailed	understanding	of	these	reported	trends.					
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Figure	1:	Total	incidence	of	AKI	per	quarter.	
A:	Total	number	of	all	cause	AKI	episodes	per	quarter.	*,	p<0.001	vs.	all	other	
quarters.		B:	Total	number	of	hospital	acquired	AKI	episodes	per	quarter.	*,	
p<0.001	vs.	all	other	quarters;	#,	p<0.001	vs.	Jan-Mar;	§,	p<0.05	vs.	Jan-Mar.	C:	
Total	number	of	community	acquired	AKI	episodes	per	quarter.	*,	p<0.001	vs.	all	
other	quarters;	#,	p<0.001	vs.	Oct-Dec	and	Jan-Mar;	§,	p<0.05	vs.	Jul-Sep	and	
p=0.008	vs.	Jan-Mar.	
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Table	1:	Seasonal	changes	in	number,	patient	characteristics,	AKI	stage	and	
outcome	of	All	AKI	episodes.		
	
	
Annual	
total	
Jan-	Mar	 Apr-Jun	 Jul-Sep	 Oct-Dec	 P	value	
Number	of	
episodes,	n	
(%	of	total)	
48457	
	
12674	
(26.2)	
12329	
(25.4)	
12116	
(25.0)	
11338	
(23.4)	
P<0.001	
Mean	age	
(yrs)	
70.4	 70.8	 70.1	 70.2	 70.2	 n/s	
Proportion	of	
males,	n	(%)	
22861	
(47.2)	
5990	
(47.3)	
5853	
(47.5)	
5669	
(46.8)	
5349	
(47.2)	
n/s	
%	with	pre-
existing	CKD	
33.1	 34.2	 32.3	 32.9	 32.9	 n/s	
AKI	stage,	n	(%)	
AKI1	
37405	
(77.2)	
9655	
	(76.2)	
	9476	
(76.9)	
9510		
(78.5)	
8767		
(77.3)	
n/s	AKI2	
7157	
(14.8)	
1924	
	(15.2)	
1873	
	(15.2)	
1679	
(13.9)	
1681	
(14.8)	
AKI3	
3895	
(8.0)	
1098		
(8.7)	
980		
(7.9)	
927	
	(7.7)	
890	
	(7.8)	
90-day	
mortality,	n	
(%)	
13080	
(27.3)	
3694		
(29.4)	
3179		
(26.1)	
3061	
(25.6)	
3146		
28.1)	
P<0.001	
Jan-
Mar/Oct-
Dec	vs.	
Apr-
Jun/Jul-
Sep	
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Table	2:	Seasonal	changes	in	number,	patient	characteristics,	AKI	stage	and	
outcome	of	CA-AKI	episodes.		
	
Annual	
total	
Jan-	Mar	 Apr-Jun	 Jul-Sep	 Oct-Dec	 P	value	
Number	of	
episodes,	n	
(%	of	total)	
24178	
	
6265	
(25.9)	
6129	
(25.4)	
6152	
(25.5)	
5632	
(23.3)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
Mean	age	
(yrs)	 69.4	 70.1	 69.2	 69.0	 69.1	
n/s	
Proportion	
of	males,	n	
(%)	
10995	
(45.5)	
2860	
(45.7)	
2799	
(45.7)	
2787	
(45.3)	
2549	
(45.3)	
n/s	
%	with	pre-
existing	CKD	
33.2	 34.0	 32.3	 33.1	 33.7	 n/s	
AKI	stage,	n	(%)	
AKI1	 17931	
4559	
(72.8)	
4584	
(74.8)	
4663	
(75.8)	
4125	
(73.2)	
P=0.002	
AKI1	vs.	
AKI2/3	
Jan-
Mar/Oct-
Dec	vs.	
Apr-
Jun/Jul-
Sep	
AKI2	 3898	
1048	
(16.7)	
975	
(15.9)	
923	
(15.0)	
952	
(16.9)	
AKI3	 2349	
658	
(10.5)	
570	
(9.3)	
566	
(9.2)	
555	
(9.9)	
AKI	
associated	
with	ICU	
admission,	n	
(%)	
1191	
(4.9)	
320	
(5.1)	
294	
(4.8)	
269	
(4.4)	
308	
(5.5)	
P=0.04	
Jan-
Mar/Oct-
Dec	vs.	
Apr-
Jun/Jul-
Sep	
90-day	
mortality,	n	
(%)	
5206	
(21.8)	
1482	
(23.9)	
1218	
(20.1)	
1198	
(19.7)	
1308	
(23.6)	
P<0.001	
Jan-
Mar/Oct-
Dec	vs.	
Apr-
Jun/Jul-
Sep	
CA-AKI	sub-group	seasonal	incidence	
GP-AKI,	n	
(%)	
7626	
	
1915	
(25.1)	
2024	
(26.5)	
2022	
(26.5)	
1665	
(21.8)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
A&E	AKI,	n	
(%)	
11693	
	
3197	
(27.3)	
2867	
(24.5)	
2873	
(24.6)	
2756	
(23.6)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
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AKI	
admitted,	n	
(%)	
10368	
2784	
(26.9)	
2568	
(24.8)	
2535	
(24.5)	
2481	
(23.9)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
CA-AKI	Not	
admitted,	n	
(%)	
13810	
	
3481	
(28.9)	
3561	
(25.8)	
3617	
(26.2)	
3151	
(22.8)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
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Table	3:	Seasonal	changes	in	number,	patient	characteristics,	AKI	stage	and	
outcome	of	HA-AKI	episodes.		
	
	
Annual	
total	
Jan-	Mar	 Apr-Jun	 Jul-Sep	 Oct-Dec	 P	value	
Number	of	
episodes,	n	
(%	of	total)	
19878	
	
5333	
(26.8)	
5120	
(25.8)	
4857	
(24.4)	
4568	
(22.9)	
P<0.001	
Oct-Dec	
vs.	Jan-
Mar/Apr-
Jun/Jul-
Sep	
Mean	age	
(yrs)	 69.4	 70.1	 69.2	 69.0	 69.1	
n/s	
Proportion	
of	males,	n	
(%)	
9554	
(48.1)	
	2567	
(48.1)	
	2467	
(48.2)	
	2291	
(47.2)	
2229	
(48.8)		
n/s	
%	with	
pre-
existing	
CKD	
33.8	 35.2	 33.4	 33.8	 32.6	 n/s	
AKI	stage,	n	(%)	
AKI1		
	16279	
(81.9)	
	4355	
(81.6)	
	4128	
(80.6)	
	4010	
(82.6)	
	3786	
(82.9)	
n/s	AKI2	
	2495	
(12.6)	
	666	
(12.5)	
	698	
(13.6)	
	593	
(12.2)	
	538	
(11.8)	
AKI3	
	1106	
(5.6)	
	313	
(5.9)	
	294	
(5.7)	
	254	
(5.2)	
	245		
(5.4)	
AKI	
associated	
with	ICU	
admission,	
n	(%)	
	1028	
(5.4)	
284	
(5.6)	
245	
(5.0)	
237	
(5.0)	
262	
(5.9)	
n/s	
90-day	
mortality,	
n	(%)	
	6924	
(33.2)	
	1855	
(35.1)	
	1636	
(32.3)	
	1530	
(31.9)	
	1503	
(33.2)	
P=0.003	
Jan-
Mar/Oct-
Dec	vs.	
Apr-
Jun/Jul-
Sep	
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Table	4:	Seasonal	variation	in	HA-AKI	by	location	(Medical	specialty)	of	AKI	
alert:	n	(%	in	quarter).		
	
	
Annu
al	
total	
Jan-	Mar	 Apr-Jun	 Jul-Sep	 Oct-Dec	
P	
value	
Medical	Specialties	
Internal	Medicine	 5000	
1342	
(26.8)	
1258	
(25.2)	
1265	
(25.3)	
1135	
(22.7)	
P<0.00
1	
Care	of	the	elderly	 1946	
533	
(27.4)	
492	
(25.3)	
483	
(24.8)	
438	
(22.5)	
P=0.00
5	
Cardiology	 1730	
470	
(27.2)	
444	
(25.7)	
413	
(23.9)	
403	
(23.3)	
P=0.03	
Gastroenterology	 915	
229	
(25.0)	
251	
(27.4)	
239	
(26.1)	
196	
(21.4)	
P=0.02	
Thoracic	Medicine	 876	
252	
(28.8)	
245	
(27.9)	
214	
(24.4)	
165	
(18.8)	
P<0.00
1	
Haem/Oncology	 529	
136	
(25.7)	
133	
(25.1)	
119	
(22.5)	
141	
(26.5)	
n/s	
Endocrinology	 318	
90	
(28.3)	
85	
(26.7)	
79	
(24.8)	
64	
(20.1)	
n/s	
Surgical	Specialties	
General	Surgery	 2511	
682	
(27.2)	
630	
(25.1)	
596	
(23.3)	
603	
(24.1)	
P=0.02	
Trauma	&	
Orthopaedic	
1694	
427	
(25.2)	
414	
(28.7)	
422	
(24.9)	
431	
(25.4)	
n/s	
Urology	 703	
177	
(25.2)	
202	
(28.7)	
171	
(24.2)	
153	
(21.7)	
P=0.02	
Gynaecology	 244	
65	
(26.6)	
62	
(25.4)	
58	
(23.8)	
59	
(24.2)	
n/s	
Obstetrics		 246	
58	
(23.6)	
79	
(32.1)	
53	
(21.5)	
56	
(22.8)	
n/s	
Cardiothoracic	
Surgery	
237	
64	
(27.0)	
63	
(26.6)	
54	
(22.8)	
56	
(23.6)	
n/s	
Anaesthetics	
/ICU	
218	
59	
(27.1)	
67	
(30.7)	
51	
(23.4)	
41	
(18.8)	
P=0.02	
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